1. Home
  2. CETX vs CNSP Comparison

CETX vs CNSP Comparison

Compare CETX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$2.87

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$5.65

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
CNSP
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.8M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
CETX
CNSP
Price
$2.87
$5.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
8.6M
21.6K
Earning Date
02-13-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,488,088.00
N/A
Revenue This Year
$19.77
N/A
Revenue Next Year
$15.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.39
N/A
52 Week Low
$2.10
$4.93
52 Week High
$49.10
$114.00

Technical Indicators

Market Signals
Indicator
CETX
CNSP
Relative Strength Index (RSI) 49.29 45.18
Support Level $2.49 $5.20
Resistance Level $2.83 $6.17
Average True Range (ATR) 0.36 0.48
MACD 0.07 -0.03
Stochastic Oscillator 59.37 40.10

Price Performance

Historical Comparison
CETX
CNSP

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: